Literature DB >> 20586849

Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by Helicobacter heilmannii infection.

Masahiko Nakamura1, Hidenori Matsui, Tetsufumi Takahashi, Satoshi Ogawa, Ryo Tamura, Somay Y Murayama, Shinichi Takahashi, Kanji Tsuchimoto.   

Abstract

BACKGROUND AND AIMS: Our recent study revealed that per oral infection with Helicobacter heilmannii induced low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric fundus of C57BL/6 mice after a period of 6 months, although the pathophysiological mechanism of lymphoma expansion remains to be clarified. The present study was undertaken to elucidate the interaction of this tumor with angiogenesis and lymphangiogenesis. In addition, the effect of Flt-4 antibodies on lymphoma expansion was investigated.
METHODS: C57BL/6 female mice infected with H. heilmannii for 3 months were used in the experiments. Localization of vascular endothelial growth factor C (VEGF-C) and Flt-4 immunoreactivity were detected by indirect immunohistochemical methods. Localization of lymphatic and vascular endothelial cells was investigated by localization of prox-1. In addition, Flt-4 antibody with and without Flt-1 or Flk-1 antibodies was administered i.p. to clarify their effects on tumor size.
RESULTS: MALT lymphoma has a rich microvascular network consisting of immature capillaries, lymphatics and venules. By immunohistochemical analysis, prox-1 immunoreactivity was observed mostly in the marginal area of the lymphoma, where VEGF-C and Flt-4 immunoreactivities were also seen. Stereomicroscopic study revealed that administration of Flt-4 and Flt-1 antibodies significantly reduced the surface area of the lymphoma in the mouse stomach.
CONCLUSION: A VEGF-C-mediated mechanism plays an important role in the expansion of MALT lymphoma and the administration of VEGF receptor antibodies had a suppressive effect on tumor growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586849     DOI: 10.1111/j.1440-1746.2010.06230.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  A case of Helicobacter heilmannii-associated primary gastric mucosa-associated lymphoid tissue lymphoma achieving complete remission after eradication.

Authors:  Takuma Okamura; Yugo Iwaya; Shuichi Yokosawa; Tomoaki Suga; Norikazu Arakura; Takehisa Matsumoto; Naoko Ogiwara; Kayoko Higuchi; Hiroyoshi Ota; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2013-01-09

2.  A combination of serum anti-Helicobacter pylori antibody titer and Kyoto classification score could provide a more accurate diagnosis of H pylori.

Authors:  Toshihiro Nishizawa; Kosuke Sakitani; Hidekazu Suzuki; Tadahiro Yamakawa; Yoshiyuki Takahashi; Nobutake Yamamichi; Hidenobu Watanabe; Yasuyuki Seto; Kazuhiko Koike; Osamu Toyoshima
Journal:  United European Gastroenterol J       Date:  2019-01-15       Impact factor: 4.623

Review 3.  Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.

Authors:  Nadine Kutsch; Reinhard Marks; Richard Ratei; Thomas K Held; Martin Schmidt-Hieber
Journal:  Biomark Insights       Date:  2015-08-16

4.  New pharmaceutical treatment of gastric MALT lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib.

Authors:  Masahiko Nakamura; Tetsufumi Takahashi; Hidenori Matsui; Shinichi Takahashi; Somay Y Murayama; Hidekazu Suzuki; Kanji Tsuchimoto
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.